showed that baseline cell-associated IGFBP3 levels in airway epithelial cells of patients with allergic asthma were higher than those of healthy donors, and that these levels increased significantly with disease severity and deterioration of lung function, which could be used as a marker of the inflammatory response in asthma. This evidence concerns the gene IGFBP3 and allergic asthma.